Literature DB >> 28035535

The Role of the Gastrointestinal Microbiota in Visceral Pain.

Kieran Rea1, Siobhain M O'Mahony1,2, Timothy G Dinan1,3, John F Cryan4,5.   

Abstract

A growing body of preclinical and clinical evidence supports a relationship between the complexity and diversity of the microorganisms that inhabit our gut (human gastrointestinal microbiota) and health status. Under normal homeostatic conditions this microbial population helps maintain intestinal peristalsis, mucosal integrity, pH balance, immune priming and protection against invading pathogens. Furthermore, these microbes can influence centrally regulated emotional behaviour through mechanisms including microbially derived bioactive molecules (amino acid metabolites, short-chain fatty acids, neuropeptides and neurotransmitters), mucosal immune and enteroendocrine cell activation, as well as vagal nerve stimulation.The microbiota-gut-brain axis comprises a dynamic matrix of tissues and organs including the brain, autonomic nervous system, glands, gut, immune cells and gastrointestinal microbiota that communicate in a complex multidirectional manner to maintain homeostasis and resist perturbation to the system. Changes to the microbial environment, as a consequence of illness, stress or injury, can lead to a broad spectrum of physiological and behavioural effects locally including a decrease in gut barrier integrity, altered gut motility, inflammatory mediator release as well as nociceptive and distension receptor sensitisation. Centrally mediated events including hypothalamic-pituitary-adrenal (HPA) axis, neuroinflammatory events and neurotransmitter systems are concomitantly altered. Thus, both central and peripheral pathways associated with pain manifestation and perception are altered as a consequence of the microbiota-gut-brain axis imbalance.In this chapter the involvement of the gastrointestinal microbiota in visceral pain is reviewed. We focus on the anatomical and physiological nodes whereby microbiota may be mediating pain response, and address the potential for manipulating gastrointestinal microbiota as a therapeutic target for visceral pain.

Entities:  

Keywords:  Brain; Gut; IBS; Microbiota; Pain

Mesh:

Year:  2017        PMID: 28035535     DOI: 10.1007/164_2016_115

Source DB:  PubMed          Journal:  Handb Exp Pharmacol        ISSN: 0171-2004


  13 in total

1.  Resveratrol alleviates temporomandibular joint inflammatory pain by recovering disturbed gut microbiota.

Authors:  Yajing Ma; Sufang Liu; Hui Shu; Joshua Crawford; Ying Xing; Feng Tao
Journal:  Brain Behav Immun       Date:  2020-01-27       Impact factor: 19.227

Review 2.  Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.

Authors:  Kumar Ganesan; Sookja Kim Chung; Jairam Vanamala; Baojun Xu
Journal:  Int J Mol Sci       Date:  2018-11-22       Impact factor: 5.923

3.  High and Mighty? Cannabinoids and the microbiome in pain.

Authors:  Kieran Rea; Siobhain M O' Mahony; John F Cryan
Journal:  Neurobiol Pain       Date:  2021-02-16

Review 4.  Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.

Authors:  Fernanda Cristofori; Vanessa Nadia Dargenio; Costantino Dargenio; Vito Leonardo Miniello; Michele Barone; Ruggiero Francavilla
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

5.  Fecal microbiota profile in a group of myasthenia gravis patients.

Authors:  German Moris; Silvia Arboleya; Leonardo Mancabelli; Christian Milani; Marco Ventura; Clara G de Los Reyes-Gavilán; Miguel Gueimonde
Journal:  Sci Rep       Date:  2018-09-26       Impact factor: 4.379

6.  Key role of gut microbiota in anhedonia-like phenotype in rodents with neuropathic pain.

Authors:  Chun Yang; Xi Fang; Gaofeng Zhan; Niannian Huang; Shan Li; Jiangjiang Bi; Riyue Jiang; Ling Yang; Liying Miao; Bin Zhu; Ailin Luo; Kenji Hashimoto
Journal:  Transl Psychiatry       Date:  2019-01-31       Impact factor: 6.222

Review 7.  The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge.

Authors:  Amir Mari; Fadi Abu Baker; Mahmud Mahamid; Wisam Sbeit; Tawfik Khoury
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

Review 8.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

9.  Drinking Refined Deep-Sea Water Improves the Gut Ecosystem with Beneficial Effects on Intestinal Health in Humans: A Randomized Double-Blind Controlled Trial.

Authors:  Hiroaki Takeuchi; Keiro Higuchi; Yu Yoshikane; Ryo Takagi; Shinji Tokuhiro; Koichi Takenaka; Wataru Oboshi; Asako Kimura; Jahirul Md Islam; Ayami Kaneko; Shouichi Sato; Satoshi Ishizuka
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

10.  Extragastrointestinal Symptoms and Sensory Responses During Breath Tests Distinguish Patients With Functional Gastrointestinal Disorders.

Authors:  Clive H Wilder-Smith; Asbjørn M Drewes; Andrea Materna; Søren S Olesen
Journal:  Clin Transl Gastroenterol       Date:  2020-08       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.